Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiparameter prediction of myeloid neoplasia risk.
Gu M, Kovilakam SC, Dunn WG, Marando L, Barcena C, Mohorianu I, Smith A, Kar SP, Fabre MA, Gerstung M, Cargo CA, Malcovati L, Quiros PM, Vassiliou GS. Gu M, et al. Among authors: dunn wg. Nat Genet. 2023 Sep;55(9):1523-1530. doi: 10.1038/s41588-023-01472-1. Epub 2023 Aug 24. Nat Genet. 2023. PMID: 37620601 Free PMC article.
Prevalence and significance of DDX41 gene variants in the general population.
Cheloor Kovilakam S, Gu M, Dunn WG, Marando L, Barcena C, Nik-Zainal S, Mohorianu I, Kar SP, Fabre MA, Quiros PM, Vassiliou GS. Cheloor Kovilakam S, et al. Among authors: dunn wg. Blood. 2023 Oct 5;142(14):1185-1192. doi: 10.1182/blood.2023020209. Blood. 2023. PMID: 37506341 Free article.
Author Correction: Multiparameter prediction of myeloid neoplasia risk.
Gu M, Kovilakam SC, Dunn WG, Marando L, Barcena C, Mohorianu I, Smith A, Kar SP, Fabre MA, Gerstung M, Cargo CA, Malcovati L, Quiros PM, Vassiliou GS. Gu M, et al. Among authors: dunn wg. Nat Genet. 2023 Oct;55(10):1777. doi: 10.1038/s41588-023-01532-6. Nat Genet. 2023. PMID: 37726541 Free PMC article. No abstract available.
Clonal hematopoiesis and hematological malignancy.
Dunn WG, McLoughlin MA, Vassiliou GS. Dunn WG, et al. J Clin Invest. 2024 Oct 1;134(19):e180065. doi: 10.1172/JCI180065. J Clin Invest. 2024. PMID: 39352393 Free PMC article. Review.
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial.
Harrison CN, Nangalia J, Boucher R, Jackson A, Yap C, O'Sullivan J, Fox S, Ailts I, Dueck AC, Geyer HL, Mesa RA, Dunn WG, Nadezhdin E, Curto-Garcia N, Green A, Wilkins B, Coppell J, Laurie J, Garg M, Ewing J, Knapper S, Crowe J, Chen F, Koutsavlis I, Godfrey A, Arami S, Drummond M, Byrne J, Clark F, Mead-Harvey C, Baxter EJ, McMullin MF, Mead AJ. Harrison CN, et al. Among authors: dunn wg. J Clin Oncol. 2023 Jul 1;41(19):3534-3544. doi: 10.1200/JCO.22.01935. Epub 2023 May 1. J Clin Oncol. 2023. PMID: 37126762 Free PMC article. Clinical Trial.
Diverse roles for T-bet in the effector responses required for resistance to infection.
Harms Pritchard G, Hall AO, Christian DA, Wagage S, Fang Q, Muallem G, John B, Glatman Zaretsky A, Dunn WG, Perrigoue J, Reiner SL, Hunter CA. Harms Pritchard G, et al. Among authors: dunn wg. J Immunol. 2015 Feb 1;194(3):1131-40. doi: 10.4049/jimmunol.1401617. Epub 2015 Jan 2. J Immunol. 2015. PMID: 25556247 Free PMC article.